menu
    • menu

    Company profile for Hoth Therapeutics

    NEW Drugs in Dev: 17
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hoth Therapeutics is a development stage biopharmaceutical company focused on proprietary therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. To treat indications impacting more than 32 million Americans, Hoth is working to develop and commercialize the BioLexa™ Platform, a proprietary, patented, drug compound platform developed at the University of Cincinnati. The BioLexa Pl...
    Hoth Therapeutics is a development stage biopharmaceutical company focused on proprietary therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. To treat indications impacting more than 32 million Americans, Hoth is working to develop and commercialize the BioLexa™ Platform, a proprietary, patented, drug compound platform developed at the University of Cincinnati. The BioLexa Platform has achieved positive results at preclinical studies conducted at the University of Miami.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hoth TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Rockefeller Plaza Suite 1039 New York, New York 10020
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hoththerapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hoth Therapeutics Pivots to AI in Space, Stock Rockets
    Hoth Therapeutics Pivots to AI in Space, Stock Rockets

    28 May 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/hoth-therapeutics-pivot-ai-space-sees-stock-price-rocket-after-rebrand

    FIERCE BIOTECH
    28 May 2026
    Share Share
    Hoth Therapeutics Gets US Patent for HT-KIT Oncology Platform
    Hoth Therapeutics Gets US Patent for HT-KIT Oncology Platform

    26 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-awarded-us-patent-for-cancer-fighting-ht-kit-oncology-platform-302781296.html

    PR NEWSWIRE
    26 May 2026
    Share Share
    Hoth Therapeutics Gets Spain Approval for HT-001 Phase 2a
    Hoth Therapeutics Gets Spain Approval for HT-001 Phase 2a

    05 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-secures-european-authorization-in-spain-for-ht-001-phase-2a-trial-as-interim-data-show-strong-efficacy-in-cancer-patients-302762976.html

    PR NEWSWIRE
    05 May 2026
    Share Share
    Hoth Therapeutics Reports Positive HT-VA CRADA Data
    Hoth Therapeutics Reports Positive HT-VA CRADA Data

    13 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-hoth-reports-positive-ht-va-crada-data-gdnf-reprograms-liver-fat-metabolism-shuts-down-fat-creation-gene-and-activates-fat-burning-pathways-outperforming-semaglutide-302740965.html

    PR NEWSWIRE
    13 Apr 2026
    Share Share
    Hoth Therapeutics Closes $2.0M Registered Direct Offering
    Hoth Therapeutics Closes $2.0M Registered Direct Offering

    02 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-closing-of-2-0-million-registered-direct-offering-302733218.html

    PR NEWSWIRE
    02 Apr 2026
    Share Share
    HT-001 Meets Primary Endpoint; Trial Expanded in Hungary
    HT-001 Meets Primary Endpoint; Trial Expanded in Hungary

    01 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hungary-approves-trial-expansion-as-ht-001-meets-primary-endpoint-in-interim-analysis-with-patients-reaching-ariga-1-by-week-six-302731156.html

    PR NEWSWIRE
    01 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search